↓ Skip to main content

Dove Medical Press

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Overview of attention for article published in Drug Design, Development and Therapy, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
47 patents

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
110 Mendeley
Title
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease
Published in
Drug Design, Development and Therapy, November 2013
DOI 10.2147/dddt.s53401
Pubmed ID
Authors

Dijana Novakovic, Marco Feligioni, Sergio Scaccianoce, Alessandra Caruso, Sonia Piccinin, Chiara Schepisi, Francesco Errico, Nicola B Mercuri, Ferdinando Nicoletti, Robert Nisticò

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Italy 1 <1%
Unknown 107 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 15%
Student > Ph. D. Student 14 13%
Researcher 14 13%
Student > Master 11 10%
Student > Postgraduate 6 5%
Other 14 13%
Unknown 34 31%
Readers by discipline Count As %
Neuroscience 14 13%
Agricultural and Biological Sciences 13 12%
Medicine and Dentistry 13 12%
Pharmacology, Toxicology and Pharmaceutical Science 12 11%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 17 15%
Unknown 37 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2020.
All research outputs
#8,713,411
of 25,806,080 outputs
Outputs from Drug Design, Development and Therapy
#662
of 2,283 outputs
Outputs of similar age
#77,526
of 227,695 outputs
Outputs of similar age from Drug Design, Development and Therapy
#19
of 40 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,283 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,695 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.